Contrary to lackluster short-term results, elective intra-aortic balloon pump (IABP) therapy in high-risk patients receiving percutaneous coronary intervention (PCI) substantially reduces all-cause ...
Intra-aortic balloon pump (IABP) therapy increases bleeding and in-hospital mortality when used during percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) or those ...
This study reviews data from 179 consecutive adult patients scheduled for primary single organ orthotopic HTx at Rikshospitalet, Oslo, Norway, between 2001 and 2007 (Figure 1). Data were ...
In the multicentre, open-label, randomized, controlled trial IABP-SHOCK II, the previously reported 30-day data demonstrated no early mortality reduction with intra-aortic balloon pump (IABP) use in ...
In a cohort of patients who underwent high-risk PCI, mechanical circulatory support with a microaxial blood pump was linked to lower odds of death, MI and cardiogenic shock compared with use of an ...
SILVER SPRING, MD — Datascope Corp/Maquet has initiated a worldwide "field correction" of certain intra-aortic balloon pump (IABP) systems to address potential electrical test failures, a MedWatch ...
DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...
DANVERS, Mass., May 18, 2023 – Abiomed, part of Johnson & Johnson MedTech [1], announces results of a third-party analysis showing that utilizing Impella during high-risk percutaneous coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback